Biochemical and biophysical characterization of lysozyme modified by PEGylation

International Journal of Pharmaceutics

Volumn 392, Issue 1-2, 2010, Pages 111-117

  da Silva Freitas, Débora ^a   Abrahão Neto, José ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antimicrobial activity; Lysozyme; PEGylation; Physical chemical stability; Proteolysis resistance

Indexed keywords

AMMONIA; CHITOSAN; GLYCOL; LYSOZYME; METHOXYPOLYETHYLENE GLYCOL 4 NITROPHENYL CARBONATE; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; CIRCULAR DICHROISM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME MODIFICATION; INFRARED SPECTROSCOPY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROCOCCUS LUTEUS; NONHUMAN; PEGYLATION; PH; PHYSICAL CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STRUCTURE; TEMPERATURE; THERMOSTABILITY;

BIOCHEMICAL PHENOMENA; BIOPHYSICAL PROCESSES; CARBONATES; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; CIRCULAR DICHROISM; DRUG CARRIERS; DRUG STABILITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HYDROGEN-ION CONCENTRATION; MICROCOCCUS; MURAMIDASE; NITROBENZENES; POLYETHYLENE GLYCOLS; PROTEIN STABILITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TEMPERATURE;

EID: 77952745485     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.03.036     Document Type: Article

References (48)

1. Abuchowski A., McCoy J.R., Palczuk N.C., Theo V.E., Davis F.F. Effect of covalent attachment of poly(ethylene glycol) on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem. 1977, 252:3582-3586.
2. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
3. Bailon P., Berthold W. Polyethylene glycol-conjugate pharmaceutical proteins. Pharm. Sci. Technol. Today 1998, 1:352-356.
4. Balan S., Choi J., Godwin A., Teo I., Laborde C.M., Heidelberger S., Zloh M., Shaunak S., Brocchini S. Site-specific PEGylation of protein disulfide bonds using a three-carbon bridge. Bioconjug. Chem. 2007, 18:61-76.
5. Caliceti P., Morpurgo M., Schiavon O., Monfardini C., Veronese F.M. Preservation of trombolytic activity of urokinase modified with monomeyhoxypoly(ethylene glycol). J. Bioact. Compat. Polym. 1994, 9:251-266.
6. Caliceti P., Veronese F.M. Pharmacokinetic and biodistribution properties of poly(ethyleneglycol) protein conjugates. Adv. Drug Deliv. Rev. 2003, 55:1261-1277.
7. Caliceti P., Schiavon O., Sartore L., Monfardini C., Veronese F.M. Active site protection of proteolytic enzymes by poly(ethylene glycol) surface modification. J. Bioact. Compat. Polym. 1993, 8:41-50.
8. Caliceti P., Schiavon O., Veronese F.M., Chaiken I.M. Effects of monomethoxypoly(ethylene glycol) modification of ribonuclease on antibody recognition, substrate accessibility and conformational stability. J. Mol. Recognit. 1990, 3:89-93.
9. Cazalis C.S., Haller C.A., Sease-Cargo L., Chaikof E.L. C-terminal site-specific PEGylation of a truncated thrombomodulin mutant with retention of full bioactivity. Bioconjug. Chem. 2004, 15:1005-1009.
10. Chiu H.-C., Zalipky S., Kopeckova P., Kopecek J. Enzymatic activity of chymotrypsin and its poly(ethylene glycol) conjugates toward low and high molecular weight substrates. Bioconjug. Chem. 1993, 4:290-295.
11. Colonna C., Conti B., Perugini P., Pavanetto F., Modena T., Dorati R., Ladarola P., Genta I. Site-directed PEGylation as successful approach to improve the enzyme replacement in the case of prolidase. Int. J. Pharm. 2008, 358:230-237.
12. Daly S.M., Przybycien T.M., Tilon R.D. Adsorption of polyethylene glycol modified lysozyme to silica. Langmuir 2005, 21:1328-1337.
13. Freitas, D.S., Abrahão-Neto, J., in press. Batch purification of high-purity lysozyme from egg white and characterization of the enzyme modified by PEGylation. Pharm. Biol., doi:10.3109/13880200903196859.
14. Gaertner H.F., Offord R.E. Site-specific attachment of functionalized poly(ethylene glycol) to the amino terminus of proteins. Bioconjug. Chem. 1996, 7:38-44.
15. Goodson R.J., Katre N.V. Site-directed PEGylation of recombinant interleukin-2 at its glycosylation site. Biotechnology 1990, 8:334-346.
16. Harris J.M., Chess R.B. Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discov. 2003, 3:214-221.
17. Harris J.M., Martin N.E., Modi M. Pegylation. A novel process for modifying pharmacokinetics. Drug Deliv. Syst. 2001, 40:539-551.
18. Harris J.M., Veronese F.M. Peptide and protein pegylation II--clinical evaluation. Adv. Drug Deliv. Rev. 2003, 55:1259-1260.
19. Imoto T., Yagishita K. A simple activity measurement of lysozyme. Agric. Biol. Chem. 1971, 35:1154-1156.
20. Johnson E.A., Larson A.E. Lysozyme. Antimicrobials in Food 2005, Taylor & Francis Group, New York. 3rd ed. P.M. Davidson, J.N. Sofos, A.L. Branen (Eds.).
21. Kinstler O.B., Brems D.N., Lauren S.L., Paige A.G., Hamburger J.B., Treuheit M.J. Characterization and stability of N-terminally PEGylated rhG-CSF. Pharm. Res. 1996, 13:996-1002.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
23. Lee H., Park T.G. A novel method for identifying pegylation sites of protein using biotinylated peg derivatives. J. Pharm. Sci. 2003, 92:97-103.
24. Lee L.S., Conover C., Shi C., Whitlow M., Filpula D. Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: a comparison of conjugation chemistries and compounds. Bioconjug. Chem. 1999, 10:6973-6981.
25. Lee S., Greenwald R.B., Mcguire J., Yang K., Shi C. Drug delivery systems employing 1,6-elimination: releasable poly(ethylene glycol) conjugates of proteins. Bioconjug. Chem. 2001, 12:163-169.
26. Malzert A., Boury F., Renard D., Robert P., Lavenant L., Benoit J.P., Proust J.E. Spectroscopic studies on poly(ethylene glycol)-lysozyme interactions. Int. J. Pharm. 2003, 260:175-186.
27. Masuda T., Ide N., Kitabatake N. Effects of chemical modification of lysine residues on the sweetness of lysozyme. Chem. Senses 2005, 30:253-264.
28. Meyer J.D., Manning M.C., Carpenter J.F. Effects of potassium bromide disk formation on the infrared spectra of dried model proteins. J. Pharm. Sci. 2004, 93:496-506.
29. Mine Y., Ma F., Lauriau S. Antimicrobial peptides release by enzymatic hydrolysis of hen egg white lysozyme. J. Agric. Food Chem. 2004, 52:1088-1094.
30. Monfardini C., Shiavon O., Caliceti P., Mopurgo M., Harris J.M., Veronese F.M. A branched monomethoxypoly(ethylene glycol) for protein modification. Bioconjug. Chem. 1995, 6:62-69.
31. Nodake Y., Yamasaki N. Some proprieties of a macromolecular conjugate of lysozyme prepared by modification with a monomethoxypolyethylene glycol derivative. Biosci. Biotechnol. Biochem. 2000, 64:767-774.
32. Peleg-Shulman T., Tsubery H., Mironchik M., Fridkin M., Schreider G., Shechter Y. Reversible PEGylation: a novel technology to release native interferon α2 over a prolonged period. J. Med. Chem. 2004, 47:4897-4904.
33. Polverino De Laureto P., De Filippis V., Scaramella E., Zambonin M., Fontana A. Limited proteolysis of lysozyme in trifluoroethanol, isolation and characterization of a partially active enzyme derivative. Eur. J. Biochem. 1995, 230:779-787.
34. Polverino De Laureto P., Frare E., Gottardo R., Van Dael H., Fontana A. Partly folded states of members of the lysozyme/lactalbumin superfamily: a comparative study by dichroism spectroscopy and limited proteolysis. Protein Sci. 2002, 11:2932-2946.
35. Pribic R., Stokkum I.H.M., Chapman D., Haris P.I., Bloemendal M. Protein secondary structure from fourier transform infrared and/or circular dichroism spectra. Anal. Biochem. 1993, 214:366-378.
36. Roberts M.J., Bentley M.D., Harris J.M. Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. 2002, 54:459-476.
37. Sato H., Ikeda M., Suzuki K., Hirayama K. Site-specific modification of interleukin-2 by combined use of genetic engineering techniques and transglutaminase. Biochemistry 1996, 35:13072-13080.
38. Shugar D. The measurement of lysozyme activity and ultraviolet inactivation of lysozyme. Biochem. Biophys. Acta 1952, 8:302-309.
39. Soares L.S., Guimarães G.M., Polakiewicz B., Pitombo R.N.M., Abrahão-Neto J. Effects of polyethylene glycol attachment on physicochemical and biological stability of E. coli l-asparaginase. Int. J. Pharm. 2002, 237:163-170.
40. Swank R.T., Munkers K.D. Molecular weight analysis of oligopeptides by electrophoresis in polyacrylamide gel with sodium dodecyl sulfate. Anal. Biochem. 1971, 39:462-477.
41. Veerapandian B., Salunke D.M., Vijayan M. X-ray characterization of an additional binding site in lysozyme. FEBS Lett. 1985, 186:163-167.
42. Veronese F.M. Peptide and protein PEGylation: a review of problems and solutions. Biomaterials 2001, 22:405-417.
43. Veronese F.M., Mero A. The impact of PEGylation on biological therapies. Biodrugs 2008, 22:315-329.
44. Veronese F.M., Pasut G. Pegylation, successful approach to drug delivery. Drug Disc. Today 2005, 10:1451-1458.
45. Yamada H., Matsunaga N., Domoto H., Imoto T. Dinitrophenylation as a probe for the determination of environments of amino groups in protein. Reactivities of individual amino groups in lysozyme. J. Biochem. 1986, 100:233-241.
46. Zhang J.-F., Shi L.-Y., Wei D.-Z. Chemical modification of l-asparaginase from Escherichia coli with a modified polyethyleneglycol under substrate protection conditions. Biotechnol. Lett. 2004, 26:753-756.
47. Zalipsky S. Chemistry of polyethylene glycol conjugates with biologically active molecules. Adv. Drug Deliv. Rev. 1995, 16:157-182.
48. Zalipsky S., Mullah N., Engbers C., Hutchins M.U., Kiwan R. Thiolytically cleavable dithiobenzyl urethane-linkage polymer-protein conjugates as macromolecular produgs: reversible PEGylation of proteins. Bioconjug. Chem. 2007, 18:1869-1878.